Supplementary Data from EGF Receptor and Mtorc1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors

Supplementary Table 1. Combined immunohistochemistry scores, yolk sac tumor and seminoma Supplementary Table 2. Immunohistochemistry scores for all tumors Supplementary Table 3. Sequences of primers used for quantitative RT-PCR Supplementary Figure 1. Complete blots of NCCIT and NTERA-2 cells treated with ligands. See Figure 4A for more details. Supplementary Figure 2. Complete blots of cells treated with rapamycin. See Figure 5 for more details. Supplementary Figure 3. Complete blots of NCCIT and NTERA-2 cells treated with erlotinib. See Figure 5 for more details. Supplementary Figure 4. Effect of EGFR and mTORC1 inhibitors on the viability of NCCIT cells. Supplementary Figure 5. Model depicting signaling pathways inhibited by erlotinib and rapamycin in NSGCTs